SureTrader SureTrader
Home > Boards > US Listed > Medical - Drugs >

Abbott Laboratories (ABT)

ABT RSS Feed
Add ABT Price Alert      Hide Sticky   Hide Intro
Moderator: DewDiligence
Search This Board:
Last Post: 9/16/2016 3:28:27 PM - Followers: 26 - Board type: Free - Posts Today: 0

Additional discussion of ABT, its competitors, and the
industries in which it operates may be found on the board,
Natural Resources /The Global Demographic Tailwind.


ABT Investor Relations

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
ABT
Current Price
Volume:
Bid Ask Day's Range
SureTrader
ABT News: Statement of Changes in Beneficial Ownership (4) 09/28/2016 05:06:44 PM
ABT News: Abbott Receives FDA Approval for the FreeStyle Libre Pro™ System, a Revolutionary Diabetes Sensing Technology for Healthcar... 09/28/2016 09:00:00 AM
ABT News: Notice of Effectiveness (effect) 09/27/2016 06:02:29 AM
ABT News: Malnutrition Adds $15.5 Billion Annually to Direct U.S. Medical Costs 09/21/2016 02:00:00 PM
ABT News: Abbott Hosts Conference Call for Third-Quarter Earnings 09/21/2016 09:00:00 AM
News News Alert: Statement of Changes in Beneficial Ownership (4) 09/28/2016 05:06:44 PM
PostSubject
#322   It’s official—ABT sells ophthalmology unit to JNJ for DewDiligence 09/16/16 03:28:27 PM
#321   WSJ reporting that ABT is selling its ophthalmology DewDiligence 09/16/16 02:12:23 PM
#320   ALR sues ABT to compel consummation of merger: DewDiligence 08/26/16 11:08:36 AM
#319   Muddy Waters says STJ devices at-risk from cyberhacking: #msg-124765706. DewDiligence 08/25/16 11:51:05 AM
#318   ABT’s CEO buys $46M of stock: #msg-124155254. DewDiligence 07/27/16 04:44:51 PM
#317   ABT’s 2Q16 sales in emerging markets—excluding Venezuela—grew 5% DewDiligence 07/20/16 11:16:37 AM
#316   2016 non-GAAP EPS guidance is unchanged at $2.14-2.24. DewDiligence 07/20/16 11:12:45 AM
#315   ABT +2% on solid 2Q16 results—sales in constant DewDiligence 07/20/16 10:07:24 AM
#314   FDA approves ABT’s bioabsorbable coronary stent: DewDiligence 07/05/16 11:16:31 AM
#313   Abbott Laboratories (NYSE:ABT) Releases Positive Data Regarding Tecnis venturecapp 05/09/16 01:57:46 PM
#312   ABT acquires STJ for $30.7B in cash and stock: DewDiligence 04/28/16 11:55:06 AM
#311   ABT raised 2016 guidance based on a solid DewDiligence 04/20/16 02:32:58 PM
#310   Reading between the lines on ABT’s 1Q16 CC, DewDiligence 04/20/16 09:20:50 AM
#309   FDA panel endorses ABT’s ABSORB stent by 9-0 vote: DewDiligence 03/15/16 05:27:19 PM
#308   Why I like ABT’s business model: #msg-121048041. DewDiligence 03/08/16 06:40:14 PM
#307   ABT-ALR merger items: #msg-120217001. DewDiligence 02/01/16 10:11:14 AM
#306   ABT -9% on soft 2016 guidance due to Venezuela: DewDiligence 01/28/16 10:20:42 AM
#305   ABT raises dividend for 44th(!) consecutive year: #msg-119100748. DewDiligence 12/11/15 12:41:21 PM
#304   3Q15 results and CC: #msg-117873547. DewDiligence 10/21/15 10:01:23 AM
#302   ABT’s ABSORB stent meets primary endpoint in US/Chinese DewDiligence 10/12/15 03:09:56 PM
#301   ABT -7.3%, which is unheard of. Why? DewDiligence 08/24/15 04:38:53 PM
#300   Abbott Laboratories Inc. has entered into an agreement IPO$ 08/03/15 03:05:34 PM
#299   I have no idea what you are talking about. DewDiligence 07/22/15 06:02:51 PM
#298   ABT addendum re ‘TGDT’: #msg-115616486. DewDiligence 07/22/15 06:02:13 PM
#297   Why would you expect such a deal? DewDiligence 07/22/15 09:57:17 AM
#296   ABT’s 2Q15 sales increased 11% YoY in constant DewDiligence 07/22/15 09:23:04 AM
#295   ABT to buy BGMD??, have any hearing this rab74 07/22/15 08:22:10 AM
#294   Momentum Cbdpotential 04/29/15 08:05:08 PM
#293   ABT +2% to post-ABBV-spinoff all-time high on 1Q15 results: DewDiligence 04/22/15 10:11:26 AM
#292   ABT sells $2.5B of 5-10-year bonds: #msg-111583757. DewDiligence 03/10/15 10:14:02 AM
#291   ABT’s new revenue breakdown among its four business segments: DewDiligence 03/03/15 10:13:02 AM
#290   $46.98—all-time ex-ABBV high. DewDiligence 02/20/15 12:28:30 PM
#289   Good news for infant-formula companies: #msg-110990484. DewDiligence 02/19/15 08:24:31 PM
#288   ABT +3% on solid 4Q14 results/2015 outlook—despite currency headwinds: DewDiligence 01/29/15 12:50:13 PM
#287   Marketing to China’s baby boomers: #msg-110218240. DewDiligence 01/25/15 06:42:53 PM
#286   India and China—both major oil importers—are much more DewDiligence 01/05/15 07:24:52 AM
#285   With global debt on the rise there may Miracleman 1 01/05/15 02:58:34 AM
#284   The global tailwind may be shifting more toward Miracleman 1 01/05/15 02:53:50 AM
#283   Which “headwind” are you referring to? DewDiligence 01/04/15 11:24:49 AM
#282   Well positioned for the 2015 headwind Miracleman 1 01/04/15 05:39:08 AM
#280   ABT increases dividend for 43rd(!) consecutive year: #msg-109014863. DewDiligence 12/12/14 11:41:39 AM
#279   All-time (post ABBV spin-off) high today. DewDiligence 11/11/14 11:57:27 AM
#278   ABT acquires AF-diagnostics company for $250M+: #msg-107659327. DewDiligence 10/29/14 03:48:50 PM
#277   ABT derives 57% of sales from emerging markets, DewDiligence 10/22/14 01:48:10 PM
#276   New 2014 non-GAAP EPS guidance is $2.25-2.27: #msg-107441324. DewDiligence 10/22/14 01:47:24 PM
#275   ABT-MYL ‘spinversion’ is going forward despite US tax-code changes: DewDiligence 10/22/14 01:23:31 PM
#274   ABT -2% on fallout from ABBV-SHPG news: #msg-107220685. DewDiligence 10/15/14 10:50:22 AM
#273   Buy backs are always a good sign and Dr Ronald MarquezPHD 09/23/14 05:54:52 PM
#272   US Treasury’s new rules would appear to prohibit DewDiligence 09/23/14 11:06:13 AM
#271   New $3B share-buyback plan: #msg-106178039. DewDiligence 09/11/14 02:07:09 PM
PostSubject